For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Former public offices
Economist, Financial Sector Policy Branch, Department of Finance (1998–2000)
Research Associate: Task Force on the Future of the Canadian Financial Services Sector, Financial Sector Policy Branch, Department of Finance (1997–1997)
Jocelyne Voisin · ADM Health Canada, Health Canada (HC)
Discussions related to supply and shortages of drugs in Canada, including the Multi-Stakeholder Steering Committee.Read more
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services.
Inter-provincial harmonization and trade barriers as it relates to insurance products.Read more
Discussions related to regulatory burden, including “cutting red tape”.
Impacts on Canadian insurers of proposed U.S. tax measures.
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.
Financing infrastructure projects, as it relates to investments by insurers
Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing.Read more
Roy Karam · Director of Operations, Health Canada (HC)
Stephanie Claxton · Deputy Director of Policy, Health Canada (HC)
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Daniel McDonald · Deputy Minister of Health, Health Canada (HC)
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Stephen Ellis · Member of Parliament, House of Commons
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Greg Orencsak · Deputy Minister of Health, Health Canada (HC)
Health Care reform as it relates to affordable access to prescription drugs, and high cost drugs for rare disease strategy. Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals as an association.Read more
Bryce McRae · Manager of Stakeholder Relations, House of Commons
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Stephen Ellis · Member of Parliament, House of Commons
Health Care reform as it relates to affordable access to prescription drugs, and high cost drugs for rare disease strategy. Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals as an association.Read more
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.
Ian Foucher · Chief of Staff to the Minister, Innovation, Science and Economic Development Canada (ISED)
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Personal Information Protection and Electronic Documents Act: seeking workable approaches to privacy rules affecting life and health insurers when the Act is updated.
Bryce McRae · Manager of Stakeholder Relations, House of Commons
Andrew Evans · Policy Advisor, House of Commons
Aaron Wudrick · Director of Policy, House of Commons
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.Read more
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.
Jill Pilgrim · Director of Policy, Health Care Systems and Legal Affairs, Health Canada (HC)
Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Greg Orencsak · Deputy Minister of Health, Health Canada (HC)
Michelle Boudreau · Associate Assistant Deputy Minister, Health Canada (HC)
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.Read more
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Chris Forbes · Deputy Minister of Finance, Finance Canada (FIN)
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Jasraj Singh Hallan · Member of Parliament, House of Commons
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Stephen Ellis · Member of Parliament, House of Commons
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Francesco Sorbara · Member of Parliment, House of Commons
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.Read more
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Income Tax Regulations, Part III: Updating income tax rules for life insurance policies.
Luis Napoles Medina · Director of Parliamentary Affairs, Senate of Canada
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
Income Tax Regulations, Part III: Updating income tax rules for life insurance policies.
Bill C-64, An Act respecting Pharmacare; advocate for reform that will allow Canadians who access prescription medications through health benefit plans to continue to do so even for those medications covered under Bill 64.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.